Storing your newborn’s stem cells may serve as your most important healthcare decision you ever make on their behalf.
What if we told you that people are banking their newborn’s stem cells to ensure they have access to their youngest, most robust personal stem cells as clinical trials continue to develop and treat numerous conditions such as neurological disorders, injuries, diabetes, arthritis, strokes, and more…
Newborn stem cell banking is the process of isolating mesenchymal stem cells derived from the umbilical cord blood, tissue or Wharton’s jelly. These cells are ideal, as they are as young as your stem cells will ever be. If you can capture them at birth, then you should be able to save and use them for generations into the future and avoid future operations to harvest bone marrow or adipose tissue.
Current studies range from blood cancers and tumors, neurologic disorders/injuries, diabetes, wound care, and more (Dessels et al. 2018)
Studies are harnessing stem cells’ natural and inherent ability to replicate and differentiate into functional tissue, and modulate the immune system, providing progress in the treatment of conditions
Having access to your own personal stem cells provides a natural alternative to drugs and pharmaceuticals, the best bio-insurance we know of today
Studies and lab results routinely show that cells with longer telomeres (younger cells, like those from your cord blood and cord tissue) are more robust and consistently outperform those with shorter telomeres (older cells) (Burrow et al. 2017)
Storing newborn’s stem cells ensure the longest telomeres, the protective endcaps on the DNA that tell the age of the cell, which only gets shorter over time, leading to common age-related diseases
With over 7,900 clinical trials and studies underway ranging from blood cancers to tumors, having access to personal stem cells could act as bio-insurance as medical breakthroughs are rapidly accomplished in stem cells therapies
Typically, children’s banked cord blood and cord tissue samples are reserved for one-time treatments mainly for siblings in the family that might have a genetically inherited disorder such as Sickle Cell Disease
American Cell Technology ensures your child will have ample access to their own personal stem cell far beyond one-time treatments and for multiple uses
Stem cells have a promising medical future with over 7,900 ongoing clinical trials underway which makes the decision to save your baby’s cells critical. The stem cells that come from your baby’s cord blood and cord tissue are the youngest personal (autologous) stem cells available to anyone. American Cell Technology has reinvented the way cord blood and cord tissue derived stem cells are stored.